My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left without hope.” ...

Despite many advances made in the understanding of leukemia biology, therapy for acute myelogenous leukemia (AML) has remained essentially unchanged for 40 years and is, too often, debilitating ...

Acute myelogenous leukemia (AML) is seen in this stock image. Duke researchers have discovered a new combination of drugs that is more effective than chemotherapy at killing acute myeloid leukemia ...